Respironics E30 for COVID-19 patients by Philips

Philips has introduced new Respironics E30 ventilator, an emergency-use ventilator with visual and audible alarms for COVID-19 patients. The company has secured the emergency-use authorization (EUA) for the new ventilator to address the COVID-19 public emergency. The company will immediately start production and plans to manufacture 15,000 units per week.
The ventilator helps to deliver high-flow oxygen, both invasively and non invasively, for COVID-19 patients with respiratory insufficiency.
The Respironics E30 ventilator has been designed for mass production by an experienced team in respiratory care. The ventilator enables healthcare providers with a range of skill sets to treat and monitor patients in clinical and field-hospital settings. Recommended circuit set-ups include a bacterial/viral filter to reduce exposure for healthcare providers, when used invasively or noninvasively with accessories such as a full-face, non-vented mask, or helmet. On-screen respiratory monitoring will help measure and show vital ventilation-type parameters like pressure, tidal volume, respiratory rate, leak, and oxygen saturation, helping clinicians to assess therapy effectiveness. The ventilator’s visual and audible alarms offer pertinent therapy information to healthcare providers